Brielle Benyon

While Lynch syndrome may be more common than originally thought, research continues to move forward to improve the outcomes of this patient population.

The FDA approved ramucirumab (Cyramza) as a single-agent treatment for patients with hepatocellular carcinoma (HCC) with an alpha fetoprotein (AFP) of ≥ 400 ng/mL and have been previously treated with sorafenib (Nexavar).

Chemotherapy-induced peripheral neuropathy affects the daily activities of patients and survivors, but nurses can be key players in helping patients who develop the condition.

We asked patients, survivors, and caregivers to give their oncology nurses a shout out. Here's what they had to say.

The FDA approved ado-trastuzumab emtansine for the treatment of HER2-positive early breast cancer, after it showed a 50% decrease of disease or death compared with trastuzumab.

The HPV vaccine is commonly associated with preventing cervical cancer, but it plays a major role in oral cancers, too.

Despite stating that they tell their loved ones everything, there are some details that patients with gynecologic cancer tend to leave out.

The use of oral contraceptives not only decreases a woman’s risk of developing ovarian cancer, but can also decrease the risk of dying from the disease, too, according to recent research.

Take a look at what's inside our April 2019 issue.

There are special concerns for oncology nurses when treating LGBTQ patients, according to a panel of experts that presented at the 2019 Oncology Nursing Society (ONS) Annual Congress in Anaheim, CA.

Hear from the winner of the 2019 Extraordinary Healer award.

The FDA granted an accelerated approval for erdafitinib to treat patients with metastatic or locally advanced bladder cancer that harbors certain genetic mutations.

An at-home computerized program could be beneficial in treating cognitive impairment in cancer survivors.

Clinical hypnosis offers a non-pharmacological approach to managing chronic pain after cancer treatment.

Oncology nurses are often on the frontline when it comes to talking to patients about how they are feeling.

The Food and Drug Administration (FDA) expanded the approved use of palbociclib (Ibrance) capsules plus endocrine therapy to treat male patients with hormone receptor (HR)–positive, HER2-negative advanced or metastatic breast cancer, according to an announcement by the agency.

CAR-T cell therapy is greatly improving the outcomes of patients with blood cancers, but not without its own set of toxicities.

The point-of-care model was proven to work better than the referral model when it came to ensuring that patients undergo the genetic screening that they needed.

It is better to introduce the topic sooner rather than later, according to one expert.

Nurses and other healthcare providers can mitigate emotional distress and improve quality of life in patients with cancer by having earlier and more thorough conversations about their care, according to a recent study conducted at the Dana-Farber Cancer Institute.

The FDA announced today that it is working to update mammography regulations, expanding the amount of information that mammography facilities must give patients and healthcare professionals. In turn, this would result in more informed decision-making – especially when it comes to breast cancer diagnoses.

While there are some exciting advances coming down the pipeline, there is still much work to do when it comes to the molecular diagnosis of patients with renal cell carcinoma (RCC), explained David I. Quinn, MBBS, PhD, FRACP, FACP.

Check out this infographic exploring 5 ways oncology nurses can do their part to improve cancer care for their patients.

Oncology nurses must discuss treatment options and adverse events with their patients who have ovarian cancer.

Man’s best friend may eventually be healthcare’s best friend.

An expert discusses the role oncology nurses play in managing the adverse events of patients with breast cancer.

Listen to the first-ever episode of the CURE Talks Cancer Podcast: Nursing Edition.

It’s an exciting time in the world of triple-negative breast cancer (TNBC), with treatments becoming more personalized to individual cancer subtypes, explained Adam Brufsky, MD, PhD.

Financial distress puts a major burden on patients with cancer and their families. And while there are numerous resources that nurses can share with their patients to help with co-pays and other money-related issues, they are not widely discussed.